Trials / Completed
CompletedNCT03923894
the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity
A 8 Weeks, Randomized, Double-blind, Placebo-controlled Human Trial to Evaluate the Efficacy and Safety of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (actual)
- Sponsor
- Chonbuk National University Hospital · Academic / Other
- Sex
- All
- Age
- 50 Years
- Healthy volunteers
- Accepted
Summary
This study was conducted to investigated the effects of daily supplementation of Blueberry Yeast Fermentation Freeze Dying Powder on Promotion of Immunity.
Detailed description
This study was a 8-week, randomized, double-blind, placebo-controlled human trial. 100 subjects were randomly divided into Blueberry Yeast Fermentation Freeze Dying Powder extract 2.07 g or placebo group. The investigated measured Natural Killer cell activity, Cytokines, Upper respiratory infection questionnaire score, etc.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Blueberry Yeast Fermentation Freeze Dying Powder Extract | Blueberry Yeast Fermentation Freeze Dying Powder Extract 2.07 g/day for 8 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Placebo 2.07 g/day for 8 weeks. |
Timeline
- Start date
- 2019-02-14
- Primary completion
- 2019-05-14
- Completion
- 2019-05-14
- First posted
- 2019-04-23
- Last updated
- 2019-08-26
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03923894. Inclusion in this directory is not an endorsement.